Texas researchers aim to spur lung growth with nanoparticles

Researchers at the University of Texas at Arlington and UT Southwestern Medical Center are developing a drug delivery system that uses nanoparticles to bring regenerative drugs into the lungs. The biodegradable nanoparticles encapsulate the drugs and, for patients whose lungs have been partially removed or destroyed by disease, the polymer delivery system is designed to control the release of these drugs to stimulate growth. The project is funded by a $3.4 million National Institutes of Health grant through 2016. More

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…